Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

Losing extra body weight serves more than aesthetic purposes. Having a healthy weight means less chances of experiencing ...

The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

A growing number of users say Ozempic is rewiring their taste buds in ways they never saw coming. Many have complained about unexpected side effects like the Ozempic butt, the Ozempic mouth, and the ...

The 74-year-old, who served as an FDA commissioner from 1990 to 1997, turned to GLP-1 medications after battling his weight ...

In many neurodegenerative diseases, proteins misfold and clump together in brain tissue. Scientists developed a new therapy made of peptides and a sugar that naturally occurs in plants. The ...

The top reasons weight loss supplements fail and why most solutions don't address both day and night fat-burning cycles; How PhenQ works as a powerful daytime fat burner to help r ...

Northwestern scientists developed a nanofiber therapy that halts toxic protein clumping in diseases like Alzheimer’s and ALS.

Novo Nordisk has potential with a 27% upside, strong market shares, and high ROI strategies. See why we recommend a buy on ...